KFDA seeks to boost production of OTCs

The Korea Food and Drug Administration has unveiled its plan to upgrade the standardized manufacturing rules aiming at expanding the number of new over-the-counter drugs and quasi-drugs.

To this end, the health watchdog will make public a notice in the first half of this year after completion of its task force’s preparatory wok.

Under the revision plan, drug makers can develop a variety o...